Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1556061000168117 | Nucala (mepolizumab 100 mg) powder for injection, 100 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1556071000168111 | Nucala 100 mg powder for injection, 100 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nucala 100 mg powder for injection, 100 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Nucala 100 mg powder for injection, 100 mg vial | Is a | Nucala | true | Inferred relationship | Some | ||
| Nucala 100 mg powder for injection, 100 mg vial | Is a | mepolizumab 100 mg injection, vial | true | Inferred relationship | Some | ||
| Nucala 100 mg powder for injection, 100 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
| Nucala 100 mg powder for injection, 100 mg vial | has unit of use | vial | true | Inferred relationship | Some | 1073588595 | |
| Nucala 100 mg powder for injection, 100 mg vial | has intended active ingredient | mepolizumab | true | Inferred relationship | Some | 1073588594 | |
| Nucala 100 mg powder for injection, 100 mg vial | has Australian BoSS | mepolizumab | true | Inferred relationship | Some | 1073588594 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nucala 100 mg powder for injection, 1 vial | has TPUU | True | Nucala 100 mg powder for injection, 100 mg vial | Inferred relationship | Some | 1 |
| Nucala 100 mg powder for injection, 1 vial | has TPUU | True | Nucala 100 mg powder for injection, 100 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR